Standard Biotools Inc. (LAB)
NASDAQ · Healthcare
Standard Biotools Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 85.3M | 91.0M | 106.3M | 97.9M | 130.6M | 138.1M | 117.2M | 113.0M | 101.9M | 104.4M | 114.7M | 116.5M | 71.2M | 52.3M | 42.9M | 33.6M | 25.4M |
| Gross Profit | 42.5M | 44.9M | 50.5M | 37.1M | — | — | 64.3M | 61.6M | 52.0M | 58.4M | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | -110.2M | -127.5M | -76.6M | -116.2M | -67.5M | -51.0M | -51.8M | -48.2M | -58.4M | -73.2M | -50.2M | -51.8M | -18.7M | -18.1M | -18.6M | -14.6M | -18.0M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -74.9M | -138.9M | -74.7M | -190.1M | -59.2M | -53.0M | -64.8M | -59.0M | -60.5M | -76.0M | -53.3M | -52.8M | -16.5M | -19.0M | -22.5M | -16.9M | -19.1M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 382M | 353M | 79M | 78M | 76M | 72M | 67M | 49M | 39M | 29M | 29M | 28M | 26M | 25M | 20M | 2M | — |
Standard Biotools Inc. Income Statement — FAQ
Standard Biotools Inc. (LAB) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LAB's income statement history?
The chart and table above show Standard Biotools Inc.'s income statement by year and by quarter, including the growth rate.